Managing In Line Products

Achieving Operational Efficiency for Pharmaceutical Market Access

”We have worked with IntegriChain since our product launch one year ago. IntegriChain has operated as an extension of both our Finance and Market Access teams and has become a trusted advisor.”

VP, Contract & Pricing


Optimize In-Market Pharmaceutical Products

Once a therapy is in market, pharmaceutical manufacturers need to continually assess and validate the estimates, forecasts and assumptions that were made during launch. By using actual contract, pricing, channel and patient data, manufacturers can determine the effectiveness of their payer mix, channel strategy, patient conversion, and distribution flow. They can also assess whether the gross-to-net model created at launch really takes into account all/any channel inventory, contracting, patient support costs, fees, rebates, chargebacks and other sales adjustments.

IntegriChain has worked with hundreds of market access pharma teams to help them achieve operational excellence, equipping them with the tools and resources needed to streamline and adjust their strategy to manage their products.

Syringe And Drug Medicine And Market Trading Stock And Index Num

Seamlessly evolve from launch to inline product management

Gain a clear line of sight into financial performance

Utilize actual data to adjust channel and distribution strategy

Assess and benchmark patient conversion rates 

Leverage inventory analytics to achieve downstream visibility

Adjust channel and distribution strategy with accurate data

Reduce manual effort required to complete financial reporting

Improve specialty pharmacy engagement and performance

More than 200 manufacturers rely on IntegriChain’s Managed Services to help scale, pivot and operationalize.

Download the Whitepaper: The Case for Managed Services.

Chargeback data reconciliation and analytics services across GPO/IDN provider and federal contracts

Managed Care, Part D, Tricare, Medicaid rebate adjudication and contract compliance validations

Accurate management of adjustments and disputes with payers and states 

State pricing transparency administration and policy and procedure updates

Multiple managed services delivery models

Automated process to adjudicate Medicaid claims, rejecting invalid claims and eliminating over-payments

Cloud Infrastructure

Scale from Launch to the Future

Executing a best-in-class market access strategy requires a modern, adaptable infrastructure that covers everything from hardware and cloud connectivity, to applications and the myriad of data inputs necessary to satisfy the needs of finance, contracts and pricing, trade and channel, patient services, and field reimbursement teams.

With access to consulting, tailored analytics, and service delivery from a team of experts, pharmaceutical manufacturers can focus on driving the business, rather than be mired in back office and administrative processing.

Chargeback processing and credit management

Contract or product system set up and administration 

Icon Generate

Contract compliance validations

Policy and procedure updates

State pricing transparency administration

Multiple managed services delivery models

+3B industry rebates processed through our ICyte platform

Learn about Rebate Management Services.

Case Study

Achieving Operational Success for Rare Disease Therapy Using a Unified Platform

Uncover how IntegriChain helped an emerging rare disease company prepare for operational success with a standard operating blueprint that could be adjusted for the needs of each therapy.

Download the Case Study

Blog

Top 10 Market Access Challenges

Based on more than 15 years of experience with more than 250 pharmaceutical manufacturers, here are the 10 most common challenges facing Market Access operations, broken down into three critical categories.

Read the Post

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper